Similar Articles
1641 Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma
1642 Activins and activin antagonists in hepatocellular carcinoma
1643 Current role of ultrasound for the management of hepatocellular carcinoma
1644 Tumor suppressor and hepatocellular carcinoma
1645 Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma
1646 DNA methylation in hepatocellular carcinoma
1647 High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis
1648 Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma
1649 COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma
1650 Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA